Appointment booking for Dr. Carrie Alfieri, OD is currently not available.Dr. Carrie Alfieri, OD has not yet fully activated their profile on DiabetesIQ.
Dr. Carrie Alfieri, OD (she/her) is a Optometrist in Mckinney, TX with over 18 years of experience. What is your opinion of Dr. Carrie Alfieri, OD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Carrie Alfieri, OD has received over $11,668 which includes payments from the following companies:
$6,053.95 from CooperVision Inc.
$4,304.01 from Alcon Laboratories Inc
$330.94 from Visioneering Technologies, Inc.
$300.29 from Johnson & Johnson Vision Care, Inc.
$122.63 from Allergan Inc.
$119.69 from Johnson & Johnson Surgical Vision, Inc.
$112.79 from ABB Con-Cise Optical Group LLC
$106.84 from Bausch & Lomb, a division of Bausch Health US, LLC
$70.74 from Bausch and Lomb Inc.
$70.03 from Valeant Pharmaceuticals North America LLC
$48.79 from Shire North American Group Inc
$27.82 from TissueTech, Inc.
Payments received by Dr. Carrie Alfieri, OD were from the following categories:
$6,250.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!